45th Annual Meeting and Workshops
Virtual and In-Person Registration
NOW Open!
May 6 – 9, 2023
Oregon Convention Center
777 NE Martin Luther King Jr. Blvd.
Portland, OR 97237
Hotel Information
DoubleTree by Hilton Hotel Portland 1000 NE Multnomah Street Portland, Oregon 97232
Hyatt Regency Portland at the Oregon Convention Center 375 NE Holladay Street Portland, Oregon 97232
Eastlund Hotel
1021 NE Grand Avenue
Portland, Oregon 97232
Look forward to:
- Amazing content delivered by experts in cardiothoracic anesthesiology, interventional cardiology and cardiothoracic surgery
- Experts will provide didactics, small group breakout teaching, and high-yield discussions
- Problem based learning discussions, scientific abstracts, and workshops are planned to optimize attendee learning and connection on critical cardiothoracic anesthesiology topics
- Attendee networking, idea-sharing, and exhibits
This year, in-person you can:
- Attend live discussion sessions to help you discover up to date practice pathways and innovations in the field
- Register for Workshops and PBLDs tailored for YOUR educational needs
- Network with 1,200 other professionals in anesthesiology to help you gain insight into your practice and career
- Connect with industry and exhibiting companies to learn about new products and programs
List of In-Person and Online Content
|
In-Person Full Annual Meeting Experience |
Virtual Track | |
| CME Credits | Coming soon! | Coming soon! |
| 50+ sessions, Panels, and Refresher Course Lectures | ✔ | ✔ 64% of the Sessions will be available for the Virtual Track! |
| Featured Lectures: Keynote, Early Wynands Lecture, and ASA Update | ✔ | ✔ |
| Business Meeting & Awards | ✔ | ✔ |
| Plenary Lectures as Highlight Sessions | ✔ | ✔ |
| Hands-on Workshops | ✔ | |
| Problem-based Learning Discussions | ✔ | |
| Best of Meeting / Early Career & Super Echo Abstracts | ✔ | |
| 400 eAbstracts | ✔ | ✔ |
| Non-CME education in the Exhibit Hall | ✔ | |
| Reception/ Happy Hours | ✔ | |
| Industry Sponsored Symposiums | ✔ | |
| Resident, Fellow, and Medical Student Poster Sessions | ✔ | |
| Fellowship Mentor/Mentee Program | ✔ | |
| Access to the virtual track recordings through August 2023. | ✔ | ✔ |
Registration Rates
(In-Person and Virtual are the same rate)
| Member Rates: | Rate |
| Annual Meeting Only – Member-Physician | $985 |
| Annual Meeting Only – Member-Fellow | $550 |
| Annual Meeting Only – Member Resident | $550 |
| Non-Member Rates: | Rate |
| Annual Meeting Only – Non-Member-Physician | $1,450 |
| Annual Meeting Only – Non-Member-Fellow | $600 |
| Annual Meeting Only – Resident | $600 |
| Annual Meeting Only – Allied Health | $785 |
LEARNER NOTIFICATION
Society of Cardiovascular Anesthesiologists
Activity Title: 2023 Annual Meeting and Workshops
Date: May 6-9, 2023
Acknowledgement of Monetary Commercial Support
The following company provided monetary support for this CME educational activity in the form of an unrestricted educational grant: None
Acknowledgement of In-Kind Support
The following companies provided in-kind support for this CME educational activity: GE Healthcare, Philips Healthcare, Mindray, LivaNova, Getinge, Abiomed, CAE
Accreditation Statement
The Society of Cardiovascular Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Society of Cardiovascular Anesthesiologists designates this live activity for a maximum of 36.25 AMA PRA Category 1 Credits™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification in Anesthesiology™ program and MOCA® are registered trademarks of The American Board of Anesthesiology®.
CREDIT DESIGNATION
This activity offers up to 36.25 CME credits, of which 11 credits contribute the patient safety CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
Description:
Annual societal meeting that presents education and research for cardiovascular anesthesiologists.
Educational Information
Physician Practice Gap:
A gap in physician performance in echocardiography and knowledge base in cardiothoracic anesthesiology will be addressed. This conference addresses several current gaps in cardiac anesthesiology: communication and teamwork in the cardiac surgical workplace, professional advancement of anesthesiologists into leadership positions and in academia, advanced echocardiography and point of care ultrasound technique, and up to date clinical information and best practices in cardiothoracic anesthesiology practice.
Needs that Underlie the Gap
Interpret and extrapolate current knowledge, evidence, and guidelines into anesthetic decision making for perioperative management of patients undergoing cardiac, thoracic, or vascular surgical procedures.
DESIGNED to Change/Outcome: Following this activity, learners will develop competence by increasing their knowledge through a combination of hands-on learning, case-based presentations, and online lectures. Knowledge will be assessed with a pre-test and post-test.
The physicians in attendance will be able to deliver a higher quality of care in cardiothoracic anesthesiology and cardiac surgical procedures by reviewing evidence-based material that has been identified as a professional practice gap, by attending workshops to improve hands-on delivery of cardiac anesthesia care, and to improve health care delivery in the cardiothoracic surgical space. Teaching modalities will include panel discussions, hands-on workshops, and problem-based learning discussions.
Educational Objectives
After completing this activity, the participant should be better able to:
- describe the latest advances in perioperative cardiovascular medicine.
- identify current trends in clinical and bench research pertinent to cardiovascular medicine and incorporate this knowledge into understanding of the science of cardiothoracic and vascular anesthesia.
- evaluate new therapeutic techniques and diagnostic/interventional procedures in cardiothoracic and vascular anesthesiology.
- discuss quality of care issues, including applicable metrics, as mechanisms to assist with quality improvement at the learner’s institution and address value-based purchasing programs initiated by the federal government.
- discuss advances in clinical echocardiography and point-of-care ultrasound and how to use them to improve outcomes in cardiac surgical patients.
- acquire skills necessary for career progression in cardiovascular and thoracic anesthesia.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Partial credit of individual sessions is not available.
Contact Information
If you have questions regarding your CME certificate, please contact Kerim Oz, kerim@veritasamc.com.
Disclosure of Financial Relationships
As an accredited provider of the ACCME, SCA adheres to all ACCME Standards for Integrity and Independence in Accredited Continuing Education. SCA collects disclosures from all individuals who have the ability to control the content of CME activities. The following individuals in control of content development for this activity have indicated that they do have financial relationships with ACCME defined ineligible companies within the past 24 months. All financial relationships have been mitigated. All others in control of content not listed below have indicated that they have no financial relationships to disclose.
| Last Name | First Name | Disclosures (s) | Role | Method of Mitigation |
| Abernathy | James | Becton Dickinson, Advisory Board, Intelliport – Consulting Fees (Ongoing) | Speaker, Moderator, Course Director, Planning Committee Member, Faculty Presenter, Program Planner | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Bhatt | Himani | Neochord, LLC – Clinical Consultant | Planning Committee Member, Faculty Presenter | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Boncyk | Tina | Sedana Medical – Consulting Fees (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Bottiger | Brandi | Csl Behring – Consulting Fees (Ongoing) | Speaker, Moderator, Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Brodt | Jessica | Cyban Pty Ltd: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing) | Speaker, Moderator | The Education Committee has reviewed this presentation and determined that the declared financial relationships are not related to the content of this presentation. |
| Brown IV | Charles | Medtronic: Other Financial or Material Support (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Cardonell | Bradford | Edwards Lifesciences: Honoraria (Ongoing) | Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Champeau | Michael | Alcon – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Terminated, September 23, 2022); Eli Lily – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Terminated, September 23, 2022); Halyard Health Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Terminated, September 23, 2022); Merck – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Terminated, September 23, 2022); Novartis – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Terminated, September 23, 2022); Organon – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Terminated, September 23, 2022); Pfizer – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Terminated, September 23, 2022); Roche – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Terminated, September 23, 2022); RomTech-Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Spiro Robotics – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Viatris – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Terminated, September 23, 2022) | Speaker | The Education Committee has reviewed this presentation and determined that the declared financial relationships are not related to the content of this presentation. |
| Coker | Bradley | American Society of Anesthesiologist – Consulting Fees (Ongoing) | Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Domino | Karen | Edwards Lifesciences – Other Financial or Material Support (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Drzymalski | Dan | Fresenius Kabi – Honoraria (Terminated, February 10, 2021) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Essandoh | Michael | Boston ScientificS4 Medical – Consulting Fees (Ongoing), Consulting Fees (Ongoing) | Speaker, Moderator, Planning Committee Member, Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Fleming | Neal | Acacia Pharma -Other Financial or Material Support; Edwards Life Sciences – Other Financial or Material Support; Haisco Pharmaceuticals – Other Financial or Material Support, Masimo, Inc. – Other Financial or Material Support, Rostrum Medical Innovations – Other Financial or Material Support, Tsumera Pharmaceuticals – Other Financial or Material Support | Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Ghadimi | Kamrouz | Octapharma – Other Financial or Material Support (Ongoing) | Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Glas | Kathryn | Chiesi – Consulting Fees (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Grocott | Hilary | Anesthesia Labs Inc., – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Life Sciences – Honoraria (Ongoing) | Speaker, Moderator | The Education Committee has reviewed this presentation and determined that the declared financial relationships are not related to the content of this presentation. |
| Hensley | Nadia | Octapharma, USA – Consulting Fees (Ongoing), Royalties (Ongoing) | Speaker, Moderator, Planning Committee Member, Faculty Presenter, Program Planner | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Huang | Jiapeng | GE Healthcare – Consulting Fees (Ongoing); Gilead Sciences – Other Financial or Material Support (Ongoing); Potreo Medical – Other Financial or Material Support (Ongoing) | Speaker, Moderator | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Joshi | Ravi | RomTech Inc. – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing) | Speaker, Moderator, Reviewer | The Education Committee has reviewed this presentation and determined that the declared financial relationships are not related to the content of this presentation. |
| Keeyapaj | Worasak | Cerus – Honoraria (Ongoing), Other Financial or Material Support (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Kunst | Gudrun | BioMerieux – Consulting Fees (Terminated, January 24, 2023); Edwards Life Sciences – Consulting Fees (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Lester | Laeben | MDAirSupport – Other Financial or Material Support (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Lewis | Choy | Edwards Life Sciences – Consulting Fees (Ongoing); La Jolla Pharmaceutical Company – Other Financial or Material Support (Ongoing) | Speaker, Moderator | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Martin | Archer | Scientific Advisory Board – Attgeno AB – Consulting Fees (Ongoing) | Reviewer, Planning Committee Member | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Mathis | Michael | National Institutes of Health – Salary (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Mazer | David | BioAge – Consulting Fees (Ongoing); Cerus – Honoraria (Ongoing); PhaseBio – Consulting Fees (Terminated, December 31, 2022); Takeda – Honoraria (Terminated, July 19, 2022) | Speaker, Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Mazzeffi | Michael | Cellphire – Other Financial or Material Support (Terminated); HemoSonics – Consulting Fees (Terminated),Octapharma – Consulting Fees (Terminated) | Speaker, Moderator, Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| McCartney | Sharon | Humacyte – Consulting Fees (Ongoing) | Speaker, Moderator, Planning Committee Member, Faculty Presenter | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Methangkool | Emily | Edwards Lifesciences – Consulting Fees (Ongoing); UpToDate – Honoraria (Ongoing) | Moderator, Reviewer, Planning Committee Member | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Mittnacht | Alex | Cardio Ring – Consulting Fees (Ongoing); Manual Surgical Sciences – Consulting Fees (Ongoing), Manual Surgical Sciences – Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing) | Speaker, Moderator | The Education Committee has reviewed this presentation and determined that the declared financial relationships are not related to the content of this presentation. |
| Nelson | Mark | Daxor Corp – Consulting Fees (Ongoing) | Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Parwani | Purvi | Astrazeneca – Consulting Fees (Ongoing); Medtronic – Consulting Fees (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Raphael | Jacob | Octapharma USA – Consulting Fees (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Sakai | Tetsuro | Haemonetics Inc – Consulting Fees (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Shaw | Andrew | AM Pharma – Consulting Fees (Ongoing); Edwards Life Sciences – Consulting Fees (Ongoing); Novartis – Consulting Fees (Ongoing),Renibus – Consulting Fees (Ongoing); Retia – Consulting Fees (Ongoing) | Speaker, Moderator | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Shernan | Stanton | e-echocardiography.com – Other Financial or Material Support (Ongoing); Philips – Other Financial or Material Support (Ongoing) | Speaker, Moderator, Reviewer | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Shook | Douglas | Baylis – Consulting Fees (Terminated); Baylis- Honoraria (Terminated); Edwards Life Sciences – Consulting Fees (Ongoing); Edwards Life Sciences -Honoraria (Ongoing);UpToDate-Honoraria (Ongoing) | Speaker, Moderator | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Shore-Lesserson | Linda | Werfen – Honoraria (Terminated, November 12, 2022) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Spence | Jessica | AOP Pharma – Other Financial or Material Support (Ongoing) | Speaker, Moderator | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Swaminathan | Madhav | Alexion – Consulting Fees (Terminated); US2.AI – Consulting Fees (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Tuck | Benjamin | CardiacAnesthesiaBoards LLC – Consulting Fees (Ongoing) | Planning Committee Member, Faculty Presenter | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
| Vegas | Annette | Abbott Medical- Honoraria (Terminated, December 31, 2022); Springer Publishing- Royalties (Ongoing) | Speaker | No conflict of interest exists. SCA requires all individuals with financial relationships with ACCME defined ineligible companies to comply with ACCME Standards for Commercial Support. SCA has received an attestation from this presenter/planner agreeing to comply. |
As an accredited provider of the ACCME, SCA adheres to all ACCME Standards for Integrity and Independence in Accredited Continuing Education. SCA collects disclosures from all individuals who have the ability to control the content of CME activities. The following individuals in control of content development for this activity have indicated that they do have financial relationships with ACCME defined ineligible companies within the past 24 months. All financial relationships have been mitigated. All others in control of content not listed below have indicated that they have no financial relationships to disclose.
How to Get Your CME Certificate
- Go to https://www.surveymagnet.com/Magnet3/login.asp?EventKey=DWIDCGLY(link will become active at the conclusion of the meeting)
- Login and evaluate the meeting.
- Print all pages of your certificate for your records.
Message from the Scientific Program Chair
Dear Colleagues,
The Scientific Program Committee is thrilled to gather in person at the Society of Cardiovascular Anesthesiologists 45th Annual Meeting and Workshops in beautiful Portland, Oregon. The 2023 conference will celebrate the SCA’s incredible history and also marks the return of the always popular Gala Event!
Hot topics include multidisciplinary approaches to heart failure, an international panel on cardiopulmonary bypass, a mitral valve symposium, a beginner course in structural heart echocardiography and an expert panel on coagulation conundrums. And of course, we are celebrating the SCA past with a plenary session on the history of the society – learning from the past and recognizing that you are its future.
Sessions include experts from the world of cardiology, cardiothoracic surgery, perfusion, critical care medicine, regional anesthesiology, law, and finance. Specific sessions are designed for trainees as the program offers a robust choice of sessions geared toward medical students, residents, and fellows. The workshops are state of the art, hands on opportunities to learn cutting edge technology from true experts in the field.
As always, cutting edge discovery will be presented via abstract presentations, the crowd-pleasing SuperEcho returns, and the PBLDs capture a vast array of topics.
The In-Person conference will once again be the primary draw – and a virtual option to participate is also available!
We are thrilled to welcome you to Portland in 2023!
See you there!
Mary Beth Brady, MD FASE
Chair, Scientific Program Committee 2023
Jonathan Ho, MD FASE
Vice Chair, Scientific Program Committee 2023
SCIENTIFIC PROGRAM COMMITEE
Mary Beth Brady, MD FASE
Chair, Scientific Program Committee
Jonathan Ho, MD FASE
Vice-Chair,
Scientific Program Committee
Stephanie Ibekwe, MD, MPH, MS Workshop and PBLD Coordinator
James Abernathy, MD
Megan Chacon, MD
Himani V. Bhatt, DO
Mariya Geube, MD
Ankit Jain, MD
Agnieszka Trzcinka, MD
Alycia Wanat-Hawthorne, MD
Adam Dalia, MD, MBA
Michele Sumler, MD
Kelly Ural, MD
James Abernathy, MD
Nadia B. Hensley, MD
Jochen Muehlschlegel, MD
Sharon McCartney, MD, FASE
Shahzad Shaefi, MD
Randal S. Blank, MD, PhD
Patrick Wouters, MD
Tara R. Brakke, MD, FASE
Jennifer Hargrave, DO
Michael K. Essandoh, MD
Rhagavendra Govinda, MBBS, MD
Jiapeng Huang, MD, PhD
Emily Methangkool, MD
Mihai V. Podgoreanu, MD, FASE
Covid: All SCA educational programs adhere to all federal and state mandates regarding Covid-19 mitigation practices in place at the time of the conference.
Cancellation Policy: All registration cancellations and refund requests must be made in writing by April 5,2023. A refund of the full conference fee, minus a $100 administrative fee, will be given for cancellations received by that date. No refunds will be granted for requests postmarked after April 5, 2023. SCA reserves the right to substitute faculty or to cancel or reschedule sessions because of low enrollment or other unforeseen circumstances. If SCA must cancel the entire meeting, registrants will receive a full credit or refund of their paid registration fee. No refunds can be made for lodging, airfare, or any other expenses related to attending the meeting.
Media waiver: SCA may take photographs, video, and/or audio of this event for use in SCA news, as well as promotional and educational materials in print, electronic, and other media—including the SCA website. By participating in this event, you grant SCA the right to use any video, image photograph, voice, or likeness—without limitation—in its news, promotional materials, and educational and publicity efforts without compensation. All types of media will become property of SCA.
Personally Identifiable Information: By registering for this event, you agree to the collection, use, and
disclosure of Personally Identifiable Information (PII). PII includes any information that identifies you personally (e.g., name, address, e-mail address, phone number, etc.). SCA will use PII to: (a) enable your event registration; (b) review, evaluate, and administer SCA initiatives; (c) market SCA opportunities you may potentially be interested in; and (d) share your PII with third parties that perform services on behalf of SCA, such as database management, event housing, and transportation. SCA may use your PII if SCA remains active in conducting any of the above purposes. SCA will not sell your PII.